Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS

Fabiola Traina, MD, PhD, Anna M Jankowska, PhD, Valeria Visconte, PhD, Yuka Sugimoto, MD, PhD, Hadrian Szpurka, PhD, Hideki Makishima, MD, PhD, Andres Jerez, MD, Christine L. O'Keefe, PhD, Mikkael A. Sekeres, MD, MS, Anjali S. Advani, MD, Yogen Saunthararajah, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Sara T. Olalla Saad, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2011) 118 (21): 461.

https://doi.org/10.1182/blood.V118.21.461.461

Published: 2011

Journal Articles

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Blood (2011) 118 (21): 457.

https://doi.org/10.1182/blood.V118.21.457.457

Published: 2011

Journal Articles

Mechanisms of Defective Hydroxylation of 5-Methylcytosine in MDS Include Pathways Other Than TET2 and IDH1/2

Anna M Jankowska, PhD, Yun Huang, PhD, Myunggon Ko, PhD, Utz J Pape, PhD, Hideki Makishima, MD, PhD, Hadrian Szpurka, PhD, Fabiola Traina, MD, PhD, Valeria Visconte, PhD, Ramon V Tiu, MD, Mikkael A Sekeres, MD, Anjana Rao, PhD, Jaroslaw P Maciejewski, MD, PhD

Blood (2011) 118 (21): 462.

https://doi.org/10.1182/blood.V118.21.462.462

Published: 2011

Journal Articles

Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis

Hideki Makishima, MD, PhD, Hirotoshi Sakaguchi, MD, Valeria Visconte, PhD, Andres Jerez, MD, Anna M Jankowska, PhD, Kathryn M Guinta, Hideki Muramatsu, MD, PhD, Mikkael A Sekeres, MD, Seiji Kojima, MD, PhD, Ramon V. Tiu, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 271.

https://doi.org/10.1182/blood.V118.21.271.271

Published: 2011

Journal Articles

Pathogenesis of MONOSOMY 7 In BONE MARROW FAILURE SYNDROMES

Hideki Makishima, MD, PhD, Fabiola Traina, MD, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, PhD, Kathryn M Guinta, Hirotoshi Sakaguchi, MD, Christine L. O'Keefe, PhD, Hideki Muramatsu, MD, PhD, Seiji Kojima, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 2411.

https://doi.org/10.1182/blood.V118.21.2411.2411

Published: 2011

Journal Articles

Consequences of UTX Dysfunction in Myelodysplastic Syndrome

Anna M Jankowska, PhD, Hadrian Szpurka, PhD, Venugopalan Cheriyath, PhD, Kwok Peng Ng, PhD, Zhenbo Hu, MD, Michael A McDevitt, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 2427.

https://doi.org/10.1182/blood.V118.21.2427.2427

Published: 2011

Journal Articles

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Hideki Makishima, MD, PhD, Shahper N Khan, PhD, Anna M Jankowska, PhD, Yuka Sugimoto, MD, Zhenbo Hu, MD, Venugopalan Cheriyath, PhD, Reda Mahfouz, MD, Quteba Ebrahem, MD, Sergei Vatolin, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P Maciejewski, MD, PhD, FACP

Blood (2011) 118 (21): 228.

https://doi.org/10.1182/blood.V118.21.228.228

Published: 2011

Journal Articles

Spliceosome GENE MUTATIONS ARE Also PRESENT In the Diverse Mutational Spectrum of CHRONIC Myelomonocytic LEUKEMIA

Hideki Makishima, MD, PhD, Anna M Jankowska, PhD, Valeria Visconte, PhD, Ramon V. Tiu, MD, Kathryn M Guinta, Hadrian Szpurka, PhD, Yuka Sugimoto, MD, PhD, Christine L. O'Keefe, PhD, Alan F. List, MD, Mikkael A Sekeres, MD, Michael A McDevitt, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2011) 118 (21): 1402.

https://doi.org/10.1182/blood.V118.21.1402.1402

Published: 2011

Journal Articles

Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions

Andres Jerez, MD, Anna M Jankowska, PhD, Hideki Makishima, MD, Lukasz P Gondek, MD, Ramon V Tiu, MD, Christine L O‘Keefe, PhD, Azim M Mohamedali, PhD, Denise Batista, PhD, Michael A McDevitt, MD, PhD, Mikkael A Sekeres, MD, Ghulam J. Mufti, MD, Jaroslaw P Maciejewski, MD, PhD

Blood (2011) 118 (21): 2795.

https://doi.org/10.1182/blood.V118.21.2795.2795

Published: 2011

NARROW

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Mechanisms of Defective Hydroxylation of 5-Methylcytosine in MDS Include Pathways Other Than TET2 and IDH1/2

Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis

Pathogenesis of MONOSOMY 7 In BONE MARROW FAILURE SYNDROMES

Consequences of UTX Dysfunction in Myelodysplastic Syndrome

EZH2 Is Either Mutated or Downregulated in Patients with Loss of Heterozygosity of Chromosome 7/7q and Leads to Epigenetic Dysregulation Via Histone H3K27.

Spliceosome GENE MUTATIONS ARE Also PRESENT In the Diverse Mutational Spectrum of CHRONIC Myelomonocytic LEUKEMIA

Defining the Topography of Deletion 5q Using SNP-A Identifies Patients with More Aggressive Disease and Correlates with Additional Lesions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only